Misbah Tahir

Misbah Tahir (finance chief) discloses dealings in IGM Biosciences, Inc. to SEC (Form 4). In total, 35 filings cover trades dated from 13 November 2020 to 23 July 2025.

On the market, this insider has only sold: 18 sales, €305k in total. Outside the open market, there are 15 share grants and 2 option exercises. 2025 to date brings no purchases and 3 sales.

The latest filing, published on 25 July 2025, reports an open-market sale of €9,449 in IGM Biosciences, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.